The Landmark Series: Desmoid
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 28 (3), 1682-1689
- https://doi.org/10.1245/s10434-020-09395-5
Abstract
Desmoid-type fibromatosis represents a challenge in the landscape of surgical oncology, for several reasons. The tumors can be infiltrative and locally aggressive, surgery may be morbid, and patients are usually young, and thus treatment sequelae must be managed for decades. Desmoids do not have metastatic potential, therefore management strategies for desmoids have evolved to employ frontline treatments that are largely non-operative. In fact, with unpredictable and benign behavior, we now recognize that desmoids can also stabilize and regress, making active observation an option for many patients. Moreover, many medical therapies are active in the disease. We reviewed landmark studies describing contemporary issues that affect treatment recommendations for desmoid patients: prognostic factors, indication to active surveillance, role of surgical margins, postoperative radiotherapy, and the most recent expert consensus papers.Keywords
This publication has 53 references indexed in Scilit:
- Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitationsWorld Journal of Surgical Oncology, 2012
- Activity of Sorafenib against Desmoid Tumor/Deep FibromatosisClinical Cancer Research, 2011
- Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-upAnnals Of Oncology, 2011
- Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumorsGenes, Chromosomes and Cancer, 2010
- Prognostic factors for extra‐abdominal and abdominal wall desmoids: A 20‐year experience at a single institutionJournal of Surgical Oncology, 2009
- A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 casesEuropean Journal of Surgical Oncology, 2009
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid TumorsThe American Journal of Pathology, 2008
- Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patientsEuropean Journal of Surgical Oncology, 2008
- The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer NetworkRadiation Oncology, 2007
- Optimizing Treatment of Desmoid TumorsJournal of Clinical Oncology, 2007